To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Collaboration

iCAN Research and Advocacy Summit #IRL

iCAN Research and Advocacy Summit #IRL Feature Image

Editor's note: I'm excited to bring this blog to you in collaboration with my colleague Mary Short, a Research Advisor for Pediatric Capabilities and co-chair of the Pediatric Steering Committee at Lilly.

There are no voices too young to make a positive impact on clinical research. That's why attending the annual iCAN Research & Advocacy Summit has been a highlight of our summer for the past two years. iCAN Research is a global consortium of Youth Advisory Groups (YAGs) working to provide a voice for children and families in pediatric medicine, research and innovation. The annual summit brings people of diverse ages, global perspectives and health care experience levels together for a week under one roof—this year in Edinburgh, Scotland.

Our time spent at the summit was full of interesting, innovative and thought-inspiring presentations led by youth advisers, clinicians and industry leaders. Here, we spotlight just a few of the themes that emerged during the event.

Digital Health
Apps. In one word, this is how we would summarize the clinical research presentations led by the youth leaders. At the start of the week-long summit, each team of YAGs was given an assignment to design a clinical trial. With an assigned condition, such as psoriasis or Crohn's disease, and just a few key details to get them started, they were instructed to determine the trial design, dosing schedule and patient information sheet. Though it wasn't a requirement of the exercise, nearly every team assumed their study would have an app to help with solutions like better managing study visit appointments or serving as an e-diary. The industry leaders in the room considered the tension between the relatively slow research cycle compared with the fast pace of advancing digital health technology and wondered about these digital natives who expect what we consider cutting-edge to be a basic offering. Digital health in clinical research is both a challenge and an opportunity!

Ethics
A hot topic, and rightfully so, during the summit was ethics. Dr. Bob Phillips (Clinical Academic at CRD and Honorary Consultant in Paediatric/Teenage-Young Adult Oncology at Leeds Children’s Hospital) made the ethical principles come to life by linking important questions to unique and funny research examples to determine if the research was ethical. For example, to demonstrate selection bias, he displayed an image of a cat then asked two attendees if they owned a cat. Both did, and Dr. Phillips proclaimed therefore that everyone owned a cat. He then asked all attendees if they had a pet cat. As attendees raised their hands in response, he adjusted his assumption to say that 50% of all people owned a cat. That interaction led to a discussion of representative samples and the ability (or not) to generalize research findings. An image of a hedgehog as “road kill” was used to pose questions related to trial risk and if the use of placebo was ethical. His presentation had everyone laughing but also made a complicated and rather serious topic understandable and memorable. Attendees representing industry and academia agreed that this was the most fun and informative ethics presentation they’ve attended.

Connections and Community #IRL
The global nature of the iCAN community often means that iCAN members and supporters meet each other in real life (#IRL) for the first time at the annual summit. We personally had a few #IRL moments with some of our digital friends, but we also saw others having this same experience.

It was particularly heartwarming to see the outpouring of love and support for an iCAN youth member who wasn't able to travel to the summit. Whether near or far, iCAN is truly an inclusive community that values all voices.

We want to thank iCAN Research and all the youth advisors and family members who made this year's summit so powerful—we certainly have a lot to think about and are looking forward to next year's event in Kansas City!

Blog post originally appeared on LillyPad.

Tags: iCAN, Pediatric Research,

Recent Articles

COVID-19TrialsUnderway FeatureImage 22June2020

Lilly’s COVID-19 Clinical Trials are Underway

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
June 22nd, 20206 minute read

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.

COVID-19ResearchTypes FeatureImage1 19May2020

Types of Clinical Research for COVID-19

Leigh Anne Naas Headshot
Leigh Anne Naas
June 3rd, 20206 minute read

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.

AStoryofResearchVolunteers FeatureImage 6May2020-01

Meet Four Research Volunteers

Leigh Anne Naas Headshot
Leigh Anne Naas
May 13th, 20201 minute read

Over 2 million brave people take part in clinical trials every year, testing new treatments that may make life better. Meet four of those people.

InnovationInClinicalTrials TweetChatBlog 14May2020-01

Tweet Chat: Uncovering Innovation in Clinical Trials

Leigh Anne Naas Headshot
Leigh Anne Naas
May 27th, 20203 minute read

On International Clinical Trials Day, we hosted a tweet chat to generate conversation on #ClinicalTrialInnovation. If you didn’t have a chance to attend, we’ve broken down the key takeaways here.

A De-centralized Response Featured Image

Clinical Trials: A De-Centralized Response

BlogAuthor Don2 3Dec2019
Don Harder
May 4th, 20203 minute read

The quick adoption and scaling of decentralized trials will be one of the positive outcomes of having to look at the world of clinical trials in a different way. Learn more about the shift.